BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 25335945)

  • 41. A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette.
    Shepperd CJ; Eldridge AC; Errington G; Dixon M
    Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S13-24. PubMed ID: 21672597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concentrations of Cotinine and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol (NNAL) in U.S. Non-Daily Cigarette Smokers.
    Gutiérrez-Torres DS; Wang L; Blount BC; Xia B; Sosnoff CS; Shiels MS; Inoue-Choi M; Etemadi A; Freedman ND
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1165-1174. PubMed ID: 33737303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Racial differences in the relationship between tobacco dependence and nicotine and carcinogen exposure.
    St Helen G; Dempsey D; Wilson M; Jacob P; Benowitz NL
    Addiction; 2013 Mar; 108(3):607-17. PubMed ID: 22971134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of exposure to carcinogens among roll-your-own and factory-made cigarette smokers.
    Shahab L; West R; McNeill A
    Addict Biol; 2009 Jul; 14(3):315-20. PubMed ID: 19523045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.
    Radwan G; Hecht SS; Carmella SG; Loffredo CA
    Nicotine Tob Res; 2013 Jan; 15(1):130-8. PubMed ID: 22573723
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Time to first cigarette and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) levels in adult smokers; National Health and Nutrition Examination Survey (NHANES), 2007-2010.
    Branstetter SA; Muscat JE
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):615-22. PubMed ID: 23542804
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial.
    Cobb CO; Foulds J; Yen MS; Veldheer S; Lopez AA; Yingst JM; Bullen C; Kang L; Eissenberg T;
    Lancet Respir Med; 2021 Aug; 9(8):840-850. PubMed ID: 33857436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biomarkers of Exposure Among "Dual Users" of Tobacco Cigarettes and Electronic Cigarettes in Canada.
    Czoli CD; Fong GT; Goniewicz ML; Hammond D
    Nicotine Tob Res; 2019 Aug; 21(9):1259-1266. PubMed ID: 30203076
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of Nicotine and Toxicant Exposure in Users of Electronic Cigarettes and Combustible Cigarettes.
    Goniewicz ML; Smith DM; Edwards KC; Blount BC; Caldwell KL; Feng J; Wang L; Christensen C; Ambrose B; Borek N; van Bemmel D; Konkel K; Erives G; Stanton CA; Lambert E; Kimmel HL; Hatsukami D; Hecht SS; Niaura RS; Travers M; Lawrence C; Hyland AJ
    JAMA Netw Open; 2018 Dec; 1(8):e185937. PubMed ID: 30646298
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cigarette rod length and its impact on serum cotinine and urinary total NNAL levels, NHANES 2007-2010.
    Agaku IT; Vardavas CI; Connolly GN
    Nicotine Tob Res; 2014 Jan; 16(1):100-7. PubMed ID: 24057994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extensive metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers.
    Stepanov I; Upadhyaya P; Carmella SG; Feuer R; Jensen J; Hatsukami DK; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1764-73. PubMed ID: 18628430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of delivered dosage of cigarette smoke toxins on the levels of urinary biomarkers of exposure.
    Melikian AA; Djordjevic MV; Chen S; Richie J; Stellman SD
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1408-15. PubMed ID: 17627005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users.
    Benowitz NL; Flanagan CA; Thomas TK; Koller KR; Wolfe AW; Renner CC; Hughes C; Decker PA; Hatsukami DK; Murphy NJ; Patten C
    Int J Circumpolar Health; 2018 Dec; 77(1):1528125. PubMed ID: 30325719
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolites of a tobacco-specific carcinogen in urine from newborns.
    Lackmann GM; Salzberger U; Töllner U; Chen M; Carmella SG; Hecht SS
    J Natl Cancer Inst; 1999 Mar; 91(5):459-65. PubMed ID: 10070946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of Urinary Biomarkers of Exposure in Humans Using Electronic Cigarettes, Combustible Cigarettes, and Smokeless Tobacco.
    Lorkiewicz P; Riggs DW; Keith RJ; Conklin DJ; Xie Z; Sutaria S; Lynch B; Srivastava S; Bhatnagar A
    Nicotine Tob Res; 2019 Aug; 21(9):1228-1238. PubMed ID: 29868926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of maternal tobacco smoking or exposure to second-hand smoke on the levels of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine of mother and the first urine of newborn.
    Florek E; Piekoszewski W; Basior A; Merritt AT; Mazela J; Lechowicz W; Kornacka MK; Kramer L
    J Physiol Pharmacol; 2011 Jun; 62(3):377-83. PubMed ID: 21893699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toxicant exposure in cigarette reducers versus light smokers.
    Hatsukami DK; Le CT; Zhang Y; Joseph AM; Mooney ME; Carmella SG; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2355-8. PubMed ID: 17164356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
    Carmella SG; Akerkar SA; Richie JP; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
    Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
    Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of exposure biomarkers in human plasma following differing levels of tobacco-specific N-nitrosamines and nicotine in cigarette smoke.
    Zhang J; Liu X; Shi B; Yang Z; Luo Y; Xu T; Liu D; Jiang C; Du G; Lu N; Zhang C; Ma Y; Bai R; Zhou J
    Environ Res; 2022 Nov; 214(Pt 2):113811. PubMed ID: 35835167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.